July 22, 2025 • 4 mins
Welcome to Ozempic Weightloss Unlocked, where we break down the latest in news and updates on Ozempic and its sweeping impact on health, lifestyle, and medicine.
Let us start with what continues to drive the headlines. Ozempic, known generically as semaglutide, was initially designed to help manage blood sugar in type two diabetes. But it’s now become widely used for weight loss, including for people without diabetes, as doctors weigh its benefits against risks. GoodRx explains that Ozempic works by mimicking a hormone called GLP-1, which signals the brain to lessen your appetite and makes you feel full sooner, so you take in fewer calories and, over time, drop pounds. Dosage is gradually increased for safety, but significant weight loss is possible. Clinical trial data shows that people taking one milligram weekly for forty weeks lost an average of thirteen pounds, while those on two milligrams lost even more. However, while a starting dose of point two five milligrams may not cause much weight loss, higher doses and longer use can result in larger changes.
Studies highlighted by Yale University indicate that some individuals can lose up to fifteen percent of their body weight with semaglutide and related injections, which outperforms some earlier treatments. However, experts repeatedly caution listeners to remember that medical supervision is critical since not everyone is a suitable candidate for this medication.
On another front, Ozempic’s impact stretches beyond the scale. Healthline reports on a new study presented at the Endocrine Society’s annual meeting, revealing that men with obesity or type two diabetes who take GLP-1 drugs experienced improved testosterone levels. According to the study, not only did participants lose about ten percent of their body weight, their total testosterone levels increased by eighteen percent, moving many from a low to a healthier hormonal status. This supports the growing body of evidence that managing weight with GLP-1 medications can have significant secondary health benefits.
Yet, there are important new cautions. In February, the Food and Drug Administration revised Ozempic’s official label to include heightened warnings about severe pancreatitis and kidney injuries. The update follows hundreds of lawsuits and reports of adverse effects such as gastroparesis, ileus, and even intestinal blockages. While many users only experience common gastrointestinal side effects like nausea, vomiting, or stomach pain as reported by GoodRx, rare but serious risks exist. There is also increasing concern among clinicians, as noted in a JAMA commentary, about rapid muscle loss—sarcopenia—especially for older adults, since this can increase the risk of fractures and frailty.
Regarding drug safety, compounded semaglutide products—those mixed at pharmacies rather than made by the original manufacturer—are under FDA scrutiny. The FDA cautions that compounded versions, which are increasingly popular and widely used, are not vetted for safety or quality, and adverse event reports have surged. Listeners should be extremely cautious and discuss any compounded medication with their healthcare team.
For those wondering about the lasting power of weight loss on Ozempic, The Independent recently covered a new review of clinical trials which reveals a pattern many are now confronting. Patients often experience weight regain within weeks of stopping Ozempic or similar drugs. The review found that this rebound can last for around five months before weight stabilizes. The degree of regain depends on continued lifestyle changes and medication choice, highlighting the need for long-term planning and support.
From the perspective of surgical weight loss, University of California San Francisco bariatric surgeon Jonathan Carter told UCSF News that Ozempic and other GLP-1 drugs have shifted the landscape. For people with significant weight to lose, especially when other diseases are present, these drugs can be valuable, though they are not a panacea. Surgery remains the best option for some, but the arrival of more powerful and patient-friendly GLP-1 medications is expected to alter obesity care further.
There is one more emerging angle: evidence is growing that Ozempic may reduce stroke risk and certain brain injury-related complications according to MedicalXpress, pointing to benefits well beyond slimming down. This has made the drug not just a household name, but a major talking point among doctors and public health leaders.
That wraps up this edition of Ozempic Weightloss Unlocked. Thank you for tuning in. Remember to subscribe for future updates and insights. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out .css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}
Let us start with what continues to drive the headlines. Ozempic, known generically as semaglutide, was initially designed to help manage blood sugar in type two diabetes. But it’s now become widely used for weight loss, including for people without diabetes, as doctors weigh its benefits against risks. GoodRx explains that Ozempic works by mimicking a hormone called GLP-1, which signals the brain to lessen your appetite and makes you feel full sooner, so you take in fewer calories and, over time, drop pounds. Dosage is gradually increased for safety, but significant weight loss is possible. Clinical trial data shows that people taking one milligram weekly for forty weeks lost an average of thirteen pounds, while those on two milligrams lost even more. However, while a starting dose of point two five milligrams may not cause much weight loss, higher doses and longer use can result in larger changes.
Studies highlighted by Yale University indicate that some individuals can lose up to fifteen percent of their body weight with semaglutide and related injections, which outperforms some earlier treatments. However, experts repeatedly caution listeners to remember that medical supervision is critical since not everyone is a suitable candidate for this medication.
On another front, Ozempic’s impact stretches beyond the scale. Healthline reports on a new study presented at the Endocrine Society’s annual meeting, revealing that men with obesity or type two diabetes who take GLP-1 drugs experienced improved testosterone levels. According to the study, not only did participants lose about ten percent of their body weight, their total testosterone levels increased by eighteen percent, moving many from a low to a healthier hormonal status. This supports the growing body of evidence that managing weight with GLP-1 medications can have significant secondary health benefits.
Yet, there are important new cautions. In February, the Food and Drug Administration revised Ozempic’s official label to include heightened warnings about severe pancreatitis and kidney injuries. The update follows hundreds of lawsuits and reports of adverse effects such as gastroparesis, ileus, and even intestinal blockages. While many users only experience common gastrointestinal side effects like nausea, vomiting, or stomach pain as reported by GoodRx, rare but serious risks exist. There is also increasing concern among clinicians, as noted in a JAMA commentary, about rapid muscle loss—sarcopenia—especially for older adults, since this can increase the risk of fractures and frailty.
Regarding drug safety, compounded semaglutide products—those mixed at pharmacies rather than made by the original manufacturer—are under FDA scrutiny. The FDA cautions that compounded versions, which are increasingly popular and widely used, are not vetted for safety or quality, and adverse event reports have surged. Listeners should be extremely cautious and discuss any compounded medication with their healthcare team.
For those wondering about the lasting power of weight loss on Ozempic, The Independent recently covered a new review of clinical trials which reveals a pattern many are now confronting. Patients often experience weight regain within weeks of stopping Ozempic or similar drugs. The review found that this rebound can last for around five months before weight stabilizes. The degree of regain depends on continued lifestyle changes and medication choice, highlighting the need for long-term planning and support.
From the perspective of surgical weight loss, University of California San Francisco bariatric surgeon Jonathan Carter told UCSF News that Ozempic and other GLP-1 drugs have shifted the landscape. For people with significant weight to lose, especially when other diseases are present, these drugs can be valuable, though they are not a panacea. Surgery remains the best option for some, but the arrival of more powerful and patient-friendly GLP-1 medications is expected to alter obesity care further.
There is one more emerging angle: evidence is growing that Ozempic may reduce stroke risk and certain brain injury-related complications according to MedicalXpress, pointing to benefits well beyond slimming down. This has made the drug not just a household name, but a major talking point among doctors and public health leaders.
That wraps up this edition of Ozempic Weightloss Unlocked. Thank you for tuning in. Remember to subscribe for future updates and insights. This has been a quiet please production, for more check out quiet please dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out .css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to ozepic Weight Loss Unlocked, where we break down
the latest in news and updates on ozepic and its
sweeping impact on health, lifestyle, and medicine. Let us start
with what continues to drive the headlines. Ozepic, known generically
as samaglutide, was initially designed to help manage blood sugar
in type two diabetes, but it's now become widely used
(00:22):
for weight loss, including for people without diabetes, as doctors
weigh its benefits against risks. Good Rx explains that ozepic
works by mimicking a hormone called GLP one, which signals
the brain to lessen your appetite and makes you feel
full sooner, so you take in fewer calories and over
time drop pounds. Gohsage is gradually increased for safety, but
(00:47):
significant weight loss is possible. Clinical trial data shows that
people taking one milligram weekly for forty weeks lost an
average of thirteen pounds, while those on two milligrams lost
even more. However, while a starting dose of point two
five milligrams may not cause much weight loss, higher doses
and longer use can result in larger changes. Studies highlighted
(01:09):
by Yale University indicate that some individuals can lose up
to fifteen percent of their body weight with semaglutide and
related injections, which outperforms some earlier treatments. However, experts repeatedly
caution listeners to remember that medical supervision is critical since
not everyone is a suitable candidate for this medication. On
another front, Ozepic's impact stretches beyond the scale. Health Line
(01:33):
reports on a new study presented at the Endocrine Society's
annual meeting revealing that men with obesity or type two
diabetes who take GLP one drugs experienced improved testosterone levels.
According to the study, not only did participants lose about
ten percent of their body weight, their total testosterone levels
increased by eighteen percent, moving many from a low to
(01:56):
a healthier hormonal status. This supports the growing body of
evidence that managing weight with GLP one medications can have
significant secondary health benefits. Yet there are important new cautions.
In February, the Food and Drug Administration revised Ozepic's official
label to include heightened warnings about severe pancreatitis and kidney injuries.
(02:18):
The update follows hundreds of lawsuits and reports of adverse
effect such as gastroparesis ilius and even intestinal blockages. While
many users only experience common gastro intestinal side effects like nausea, vomiting,
or stomach pain, as reported by good RX, rare but
serious risks exist. There is also increasing concern among clinicians,
(02:40):
as noted in a Jarma commetary, about rapid muscle loss sarcopenia,
especially for older adults, since this can increase the risk
of fractures and failty regarding drug safety. Compounded semiglutide products,
those mixed at pharmacies rather than made by the original manufacturer,
are under FDA scrutiny. The FDA cautions that compounded versions,
(03:01):
which are increasingly popular and widely used, are not vetted
for safety or quality, and adverse event reports have surged
listeners should be extremely cautious and discuss any compounded medication
with their health care team. For those wondering about the
lasting power of weight loss on ozepic, The Independent recently
covered a new review of clinical trials which reveals a
(03:22):
pattern many and now confronting patients often experience weight regain
within weeks of stopping ozepic or similar drugs. The review
found that this rebound can last for around five months
before weight stabilizes. The degree of regain depends on continued
lifestyle changes and medication choice, highlighting the need for long
term planning and support from the perspective of surgical weight loss.
(03:44):
University of California, San Francisco bariatric surgeon Jonathan Carter told
UCSF News that ozeenpic and other GOLP one drugs have
shifted the landscape for people with significant weight to lose,
especially when other diseases are present. These drugs can be valuable,
though they are not a panacea. Surgery remains the best
option for some, but the arrival of more powerful and
(04:07):
patient friendly GLP one medications is expected to alter obesity
care further. There is one more emerging angle. Evidence is
growing that ozempic may reduce stroke risk and certain brain
injury related complications, according to Medical Express, pointing to benefits
well beyond slimming down. This has made the drug not
just a household name, but a major talking point among
(04:28):
doctors and public health leaders. That wraps up this edition
of Ozempic Weight Loss Unlocked. Thank you for tuning in.
Remember to subscribe for future updates and insights. This has
been a quiet please production. For more check out Quiet
please dot ai
Welcome to ozepic Weight Loss Unlocked, where we break down
the latest in news and updates on ozepic and its
sweeping impact on health, lifestyle, and medicine. Let us start
with what continues to drive the headlines. Ozepic, known generically
as samaglutide, was initially designed to help manage blood sugar
in type two diabetes, but it's now become widely used
(00:22):
for weight loss, including for people without diabetes, as doctors
weigh its benefits against risks. Good Rx explains that ozepic
works by mimicking a hormone called GLP one, which signals
the brain to lessen your appetite and makes you feel
full sooner, so you take in fewer calories and over
time drop pounds. Gohsage is gradually increased for safety, but
(00:47):
significant weight loss is possible. Clinical trial data shows that
people taking one milligram weekly for forty weeks lost an
average of thirteen pounds, while those on two milligrams lost
even more. However, while a starting dose of point two
five milligrams may not cause much weight loss, higher doses
and longer use can result in larger changes. Studies highlighted
(01:09):
by Yale University indicate that some individuals can lose up
to fifteen percent of their body weight with semaglutide and
related injections, which outperforms some earlier treatments. However, experts repeatedly
caution listeners to remember that medical supervision is critical since
not everyone is a suitable candidate for this medication. On
another front, Ozepic's impact stretches beyond the scale. Health Line
(01:33):
reports on a new study presented at the Endocrine Society's
annual meeting revealing that men with obesity or type two
diabetes who take GLP one drugs experienced improved testosterone levels.
According to the study, not only did participants lose about
ten percent of their body weight, their total testosterone levels
increased by eighteen percent, moving many from a low to
(01:56):
a healthier hormonal status. This supports the growing body of
evidence that managing weight with GLP one medications can have
significant secondary health benefits. Yet there are important new cautions.
In February, the Food and Drug Administration revised Ozepic's official
label to include heightened warnings about severe pancreatitis and kidney injuries.
(02:18):
The update follows hundreds of lawsuits and reports of adverse
effect such as gastroparesis ilius and even intestinal blockages. While
many users only experience common gastro intestinal side effects like nausea, vomiting,
or stomach pain, as reported by good RX, rare but
serious risks exist. There is also increasing concern among clinicians,
(02:40):
as noted in a Jarma commetary, about rapid muscle loss sarcopenia,
especially for older adults, since this can increase the risk
of fractures and failty regarding drug safety. Compounded semiglutide products,
those mixed at pharmacies rather than made by the original manufacturer,
are under FDA scrutiny. The FDA cautions that compounded versions,
(03:01):
which are increasingly popular and widely used, are not vetted
for safety or quality, and adverse event reports have surged
listeners should be extremely cautious and discuss any compounded medication
with their health care team. For those wondering about the
lasting power of weight loss on ozepic, The Independent recently
covered a new review of clinical trials which reveals a
(03:22):
pattern many and now confronting patients often experience weight regain
within weeks of stopping ozepic or similar drugs. The review
found that this rebound can last for around five months
before weight stabilizes. The degree of regain depends on continued
lifestyle changes and medication choice, highlighting the need for long
term planning and support from the perspective of surgical weight loss.
(03:44):
University of California, San Francisco bariatric surgeon Jonathan Carter told
UCSF News that ozeenpic and other GOLP one drugs have
shifted the landscape for people with significant weight to lose,
especially when other diseases are present. These drugs can be valuable,
though they are not a panacea. Surgery remains the best
option for some, but the arrival of more powerful and
(04:07):
patient friendly GLP one medications is expected to alter obesity
care further. There is one more emerging angle. Evidence is
growing that ozempic may reduce stroke risk and certain brain
injury related complications, according to Medical Express, pointing to benefits
well beyond slimming down. This has made the drug not
just a household name, but a major talking point among
(04:28):
doctors and public health leaders. That wraps up this edition
of Ozempic Weight Loss Unlocked. Thank you for tuning in.
Remember to subscribe for future updates and insights. This has
been a quiet please production. For more check out Quiet
please dot ai
Popular Podcasts
NFL Daily with Gregg Rosenthal
Gregg Rosenthal and a rotating crew of elite NFL Media co-hosts, including Patrick Claybon, Colleen Wolfe, Steve Wyche, Nick Shook and Jourdan Rodrigue of The Athletic get you caught up daily on all the NFL news and analysis you need to be smarter and funnier than your friends.
On Purpose with Jay Shetty
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com